Molecular Profiling Defines Distinct Prognostic Subgroups in Childhood AML: A Report From the French ELAM02 Study Group

Molecular Profiling Defines Distinct Prognostic Subgroups in Childhood AML: A Report From the French ELAM02 Study Group

Abstract. Despite major treatment improvements over the past decades, pediatric acute myeloid leukemia (AML) is still a life-threatening malignancy with relapse rates up to 30% and survival rates below 75%. A better description of the pattern of molecular aberrations in childhood AML is needed to re...

Full description

Bibliographic Details
Main Authors: Alice Marceau-Renaut, Nicolas Duployez, Benoît Ducourneau, Myriam Labopin, Arnaud Petit, Alexandra Rousseau, Sandrine Geffroy, Maxime Bucci, Wendy Cuccuini, Odile Fenneteau, Philippe Ruminy, Brigitte Nelken, Stéphane Ducassou, Virginie Gandemer, Thierry Leblanc, Gérard Michel, Yves Bertrand, André Baruchel, Guy Leverger, Claude Preudhomme, Hélène Lapillonne
Format: Article
Language:English
Published: Wolters Kluwer 2018-02-01
Series:HemaSphere
Online Access:http://journals.lww.com/10.1097/HS9.0000000000000031

Internet

http://journals.lww.com/10.1097/HS9.0000000000000031

Similar Items